Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Change in Accured Expenses: 2009-2012

Historic Change in Accured Expenses for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2012 value amounting to -$892,000.

  • Lexicon Pharmaceuticals' Change in Accured Expenses rose 86.36% to -$892,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $995,000, marking a year-over-year increase of 109.60%. This contributed to the annual value of $14.8 million for FY2024, which is 129.33% up from last year.
  • As of Q4 2012, Lexicon Pharmaceuticals' Change in Accured Expenses stood at -$892,000, which was down 156.82% from $1.6 million recorded in Q3 2012.
  • In the past 5 years, Lexicon Pharmaceuticals' Change in Accured Expenses ranged from a high of $6.9 million in Q4 2009 and a low of -$6.5 million during Q4 2011.
  • Its 3-year average for Change in Accured Expenses is -$344,333, with a median of $158,500 in 2012.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first tumbled by 439.44% in 2011, then spiked by 207.24% in 2012.
  • Quarterly analysis of 4 years shows Lexicon Pharmaceuticals' Change in Accured Expenses stood at $6.9 million in 2009, then tumbled by 71.89% to $1.9 million in 2010, then tumbled by 439.44% to -$6.5 million in 2011, then skyrocketed by 86.36% to -$892,000 in 2012.
  • Its Change in Accured Expenses was -$892,000 in Q4 2012, compared to $1.6 million in Q3 2012 and -$534,000 in Q2 2012.